Here we have investigated the mechanisms by which increased BCAT1 activity promotes glioblastoma progression by modulating the activity of the enzyme in patient-derived glioblastoma cells with high and very low levels of BCAT1 expression and in mouse and rat orthotopic tumor models derived from them. This evidence concerns the gene BCAT1 and neoplasm.